Capital expenditure increased 28.8%
Capital expenditure changed +28.8% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure changed +28.8% from the comparable as-filed period.
Free-cash-flow proxy changed -23.1% from the comparable as-filed period.
Operating cash flow changed +32.2% from the comparable as-filed period.
Operating income changed +26.7% from the comparable as-filed period.
Revenue changed +16.4% from the comparable as-filed period.
Capex / revenue changed +94 basis points from the comparable as-filed period.
Net income changed +9.4% from the comparable as-filed period.
Operating margin changed +27 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.